Several studies, however, suggest that Ret-Hb may not discriminate well between iron deficiency and β-thalassemia and that Ret-Hb should hence be used with caution in populations with a high prevalence of β-thalassemia, such as the patients with Mediterranean ancestry [11, 12]. This evidence concerns the gene GSTM1 and nutritional disorder.